阿达木-话题@MedSci

#阿达木#

86篇内容 | 3159人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1615610, encodeId=0c9f16156104e, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=勃林格殷格翰阿达木单抗生物类似药CYLTEZO(R)获CHMP正面意见, objectType=article, longId=113775, objectId=d781113e75b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d781113e75b8, replyNumber=0, likeNumber=60, createdTime=2017-09-24, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d781113e75b8, moduleTitle=勃林格殷格翰阿达木单抗生物类似药CYLTEZO(R)获CHMP正面意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d781113e75b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615609, encodeId=cc061615609fd, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=ANN RHEUM DIS：巴瑞克替尼vs.阿达木单抗治疗类风湿关节炎的3期研究结果, objectType=article, longId=112379, objectId=4ada1123e979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ada1123e979, replyNumber=0, likeNumber=63, createdTime=2017-09-10, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ada1123e979, moduleTitle=ANN RHEUM DIS：巴瑞克替尼vs.阿达木单抗治疗类风湿关节炎的3期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ada1123e979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615608, encodeId=dcca161560891, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=ANN RHEUM DIS：巴瑞克替尼或阿达木单抗治疗类风湿关节炎的3期研究结果, objectType=article, longId=108503, objectId=39a6108503f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39a6108503f8, replyNumber=0, likeNumber=102, createdTime=2017-08-13, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39a6108503f8, moduleTitle=ANN RHEUM DIS：巴瑞克替尼或阿达木单抗治疗类风湿关节炎的3期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39a6108503f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615607, encodeId=37e7161560e8b, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似, objectType=article, longId=107219, objectId=a78110e219d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a78110e219d2, replyNumber=0, likeNumber=74, createdTime=2017-08-01, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a78110e219d2, moduleTitle=Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a78110e219d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615606, encodeId=646a1615606c0, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较, objectType=article, longId=101283, objectId=bb5010128393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb5010128393, replyNumber=0, likeNumber=73, createdTime=2017-06-11, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb5010128393, moduleTitle=Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb5010128393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615605, encodeId=ce7916156051e, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Lancet：阿达木单抗用于重度斑块型银屑病的儿童和青少年患者, objectType=article, longId=97948, objectId=52f99e94828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52f99e94828, replyNumber=0, likeNumber=58, createdTime=2017-05-07, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52f99e94828, moduleTitle=Lancet：阿达木单抗用于重度斑块型银屑病的儿童和青少年患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52f99e94828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615604, encodeId=d1ee1615604cf, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=NEJM：阿达木单抗+甲氨蝶呤治疗青少年特发性关节炎中的葡萄膜炎, objectType=article, longId=97774, objectId=a7fb9e774e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7fb9e774e3, replyNumber=0, likeNumber=74, createdTime=2017-05-04, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7fb9e774e3, moduleTitle=NEJM：阿达木单抗+甲氨蝶呤治疗青少年特发性关节炎中的葡萄膜炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7fb9e774e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615603, encodeId=d409161560397, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=NEJM：阿达木单抗用于儿童和青少年活动性特发性关节炎相关的葡萄膜炎, objectType=article, longId=97309, objectId=f4e99e3098e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4e99e3098e, replyNumber=0, likeNumber=79, createdTime=2017-04-29, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4e99e3098e, moduleTitle=NEJM：阿达木单抗用于儿童和青少年活动性特发性关节炎相关的葡萄膜炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4e99e3098e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615602, encodeId=4eef1615602ea, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据, objectType=article, longId=94962, objectId=35079496207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35079496207, replyNumber=0, likeNumber=56, createdTime=2017-04-08, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35079496207, moduleTitle=Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35079496207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615601, encodeId=9de91615601ac, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=艾伯维香菇蓝瘦！辉瑞阿达木单抗生物仿制药PF-06410293在III期临床获得成功, objectType=article, longId=87131, objectId=d5598e13167, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5598e13167, replyNumber=0, likeNumber=49, createdTime=2017-01-11, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5598e13167, moduleTitle=艾伯维香菇蓝瘦！辉瑞阿达木单抗生物仿制药PF-06410293在III期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5598e13167)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615600, encodeId=87e5161560072, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=重磅！FDA批准美国市场阿达木单抗生物仿制药Amjevita, objectType=article, longId=78705, objectId=3d06e87059c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d06e87059c, replyNumber=0, likeNumber=52, createdTime=2016-09-29, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d06e87059c, moduleTitle=重磅！FDA批准美国市场阿达木单抗生物仿制药Amjevita, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d06e87059c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615599, encodeId=27f1161559937, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=NEJM：阿达木单抗治疗非感染性葡萄膜炎——疗效与风险并存, objectType=article, longId=77051, objectId=c286e70514c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c286e70514c, replyNumber=0, likeNumber=68, createdTime=2016-09-10, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c286e70514c, moduleTitle=NEJM：阿达木单抗治疗非感染性葡萄膜炎——疗效与风险并存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c286e70514c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615598, encodeId=310416155982c, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=NEJM：化脓性汗腺炎患者的福音——阿达木单抗, objectType=article, longId=74461, objectId=bdcae446161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdcae446161, replyNumber=0, likeNumber=76, createdTime=2016-08-06, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdcae446161, moduleTitle=NEJM：化脓性汗腺炎患者的福音——阿达木单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdcae446161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615597, encodeId=f067161559e0f, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=哪些类风湿关节炎患者阿达木单抗剂量可减半？, objectType=article, longId=64564, objectId=84056456445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84056456445, replyNumber=0, likeNumber=54, createdTime=2016-03-11, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84056456445, moduleTitle=哪些类风湿关节炎患者阿达木单抗剂量可减半？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84056456445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615596, encodeId=21f11615596bd, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Ann Rheum Dis：阿达木单抗诱导治疗类风湿关节炎的临床和影像学结果, objectType=article, longId=57932, objectId=97ec5e932f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ec5e932f5, replyNumber=0, likeNumber=86, createdTime=2015-10-29, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ec5e932f5, moduleTitle=Ann Rheum Dis：阿达木单抗诱导治疗类风湿关节炎的临床和影像学结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ec5e932f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615595, encodeId=305916155955c, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=NEJM：Guselkumab和阿达木单抗治疗斑块型银屑病, objectType=article, longId=53133, objectId=bda753133e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bda753133e1, replyNumber=0, likeNumber=89, createdTime=2015-07-11, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bda753133e1, moduleTitle=NEJM：Guselkumab和阿达木单抗治疗斑块型银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bda753133e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615594, encodeId=ac97161559484, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Arthritis Rheumatol：阿达木单抗治疗幼年特发性关节炎有效, objectType=article, longId=42809, objectId=4afb42809a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4afb42809a2, replyNumber=0, likeNumber=68, createdTime=2014-11-21, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4afb42809a2, moduleTitle=Arthritis Rheumatol：阿达木单抗治疗幼年特发性关节炎有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4afb42809a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615593, encodeId=7868161559344, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=进仿制版3期临床达到主要终点，阿达木单抗霸主地位受到威胁？, objectType=article, longId=41284, objectId=eb594128469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb594128469, replyNumber=0, likeNumber=0, createdTime=2014-10-17, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb594128469, moduleTitle=进仿制版3期临床达到主要终点，阿达木单抗霸主地位受到威胁？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb594128469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615592, encodeId=03f11615592d5, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=FDA批准阿达木单抗用于儿童节段性回肠炎, objectType=article, longId=41032, objectId=0b3541032fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3541032fe, replyNumber=0, likeNumber=72, createdTime=2014-10-11, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3541032fe, moduleTitle=FDA批准阿达木单抗用于儿童节段性回肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3541032fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615591, encodeId=191b161559135, content=<a href='/topic/show?id=3eb39e945b2' target=_blank style='color:#2F92EE;'>#阿达木#</a>, objectTitle=Ann Rheum Dis：阿达木联合甲氨蝶呤和关节内注射激素可改善早期RA, objectType=article, longId=32111, objectId=72e232111d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72e232111d5, replyNumber=0, likeNumber=69, createdTime=2014-03-21, rootId=0, userName=1179102698_36768932, userId=3dba19658752, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72e232111d5, moduleTitle=Ann Rheum Dis：阿达木联合甲氨蝶呤和关节内注射激素可改善早期RA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72e232111d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿达木

2020-05-29

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

勃林格殷格翰阿达木单抗生物类似药CYLTEZO(R)获CHMP正面意见

2017-09-24

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

ANN RHEUM DIS：巴瑞克替尼vs.阿达木单抗治疗类风湿关节炎的3期研究结果

2017-09-10

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

ANN RHEUM DIS：巴瑞克替尼或阿达木单抗治疗类风湿关节炎的3期研究结果

2017-08-13

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Br J Dermatol：治疗银屑病，生物仿制药的ABP 501与阿达木单抗的疗效、安全性、免疫原性相似

2017-08-01

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Ann Rheum Dis：生物仿制药ABP 501与阿达木单抗治疗中重度类风湿关节炎的疗效和安全性比较

2017-06-11

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Lancet：阿达木单抗用于重度斑块型银屑病的儿童和青少年患者

2017-05-07

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

NEJM：阿达木单抗+甲氨蝶呤治疗青少年特发性关节炎中的葡萄膜炎

2017-05-04

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

NEJM：阿达木单抗用于儿童和青少年活动性特发性关节炎相关的葡萄膜炎

2017-04-29

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Aliment Pharmacol Ther：巢式病例对照研究揭露克罗恩氏病患者阿达木单抗剂量降低的数据

2017-04-08

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

艾伯维香菇蓝瘦！辉瑞阿达木单抗生物仿制药PF-06410293在III期临床获得成功

2017-01-11

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

重磅！FDA批准美国市场阿达木单抗生物仿制药Amjevita

2016-09-29

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

NEJM：阿达木单抗治疗非感染性葡萄膜炎——疗效与风险并存

2016-09-10

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

NEJM：化脓性汗腺炎患者的福音——阿达木单抗

2016-08-06

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

哪些类风湿关节炎患者阿达木单抗剂量可减半？

2016-03-11

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Ann Rheum Dis：阿达木单抗诱导治疗类风湿关节炎的临床和影像学结果

2015-10-29

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

NEJM：Guselkumab和阿达木单抗治疗斑块型银屑病

2015-07-11

智智灵药 (审核中...)

前往app查看评论内容

#阿达木#

Arthritis Rheumatol：阿达木单抗治疗幼年特发性关节炎有效

2014-11-21

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

进仿制版3期临床达到主要终点，阿达木单抗霸主地位受到威胁？

2014-10-17

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

FDA批准阿达木单抗用于儿童节段性回肠炎

2014-10-11

1179102698_36768932 (审核中...)

前往app查看评论内容

#阿达木#

Ann Rheum Dis：阿达木联合甲氨蝶呤和关节内注射激素可改善早期RA

2014-03-21

科室
- - 订阅+
  - 更多科室
工具
服务